Evaluate the Safety Pharmacokinetics of a Human Monoclonal Antibody S315 Against Diphtheria Toxin in Healthy Subjects
Status:
Completed
Trial end date:
2019-10-07
Target enrollment:
Participant gender:
Summary
This study will examine the use of a single infusion of S315 at different doses in healthy
volunteers to help understand its safety and tolerability. S315 is a monoclonal antibody that
is being developed for treatment of diphtheria. The study will assess for any side effects
when S315 and will also look at the levels of S315 in the blood over time.